The Effect of Reduced Dose of Enoxaparin on the Outcomes of Treatment With Enoxaparin

The Effect of Reduced Dose of Enoxaparin on the Laboratory and Clinical Outcomes of Treatment With Enoxaparin

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00354796

Enrollment

500

Registered

2006-07-20

Start date

2006-07-31

Completion date

2015-10-31

Last updated

2011-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndrome, Atrial Fibrillation, Hypercoagulability, Venous Thromboembolism

Keywords

bleeding, anticoagulation, LMWH, Enoxaparin

Brief summary

We hypothesize that reduced dose of enoxaparin in elderly patients will result in reduced proportion of patients with therapeutic anti Xa activity and reduced clinical efficacy.

Detailed description

Patients treated with enoxaparin will be followed, sociodemographic , clinical and laboratory data will be collected. Clinical efficacy as well as adverse events will be monitored.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* treatment with enoxaparin

Exclusion criteria

* no

Countries

Israel

Contacts

Primary ContactMordechai Muszkat, MD

muszkatm@hadassah.org.il00-972-2-6776449

Outcome results